ProShares Ultra Nasdaq Biotechnology (NasdaqGS: BIB)
YTD: 155.7%
Comment: BIB is the double-leveraged equivalent of one this year’s best industry ETFs: The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB). Both are triple-digit ETFs and a double-leveraged bet on IBB means a big bet on the largest biotech names, such as Amgen (NasdaqGM: AMGN) and Celegene (Nasdaq: CELG).